German Cancer Research Center

This early-phase trial tests a new vaccine called PANHPVAX in 45 healthy adults aged 18-45. The vaccine targets a part of the HPV virus (L2 antigen) to potentially prevent HPV infections. The main goal is to check safety and how well the body's immune system responds to different…

This study tests whether using a person's unique tumor genetics to choose their treatment works better than standard care for advanced rare cancers. About 946 adults with rare epithelial or mesenchymal cancers will be randomly assigned to either immediate genetically guided thera…

This study enrolls 5,000 people with metastatic breast cancer to analyze their tumor and blood samples for genetic markers. The goal is to identify which patients might benefit from specific targeted therapies and connect them to appropriate clinical trials. Participants continue…